One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1002/ajh.26847
Copy DOI Journal: American journal of hematology |  Publication Date: Feb 6, 2023 |
 Citations: 3 |  License type: CC BY-NC-ND 4.0 |
Affiliation: University Hospital Ulm, Bristol-Myers Squibb (United States), The University of Texas MD Anderson Cancer Center, Royal Melbourne Hospital, The Alfred Hospital, Monash University, Assistance Publique – Hôpitaux de Paris, Université Paris Cité, University of Helsinki, Hospital Universitari i Politècnic La Fe, University of Kansas, AZ Sint-Jan, Indiana University, Cornell University, NewYork–Presbyterian Hospital, Samsung (South Korea)Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial.
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
